Cargando…

The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody

Detalles Bibliográficos
Autores principales: Sansal-Castellano, Isabelle, Carlson, Mark, Reznik, Gabriel, Siedlecki, James, Kane, John, Dostalova, Zuzana, Miao, Hua, Rubin-Bejerano, Ifat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652514/
http://dx.doi.org/10.1186/2051-1426-3-S2-P414
_version_ 1782401770788487168
author Sansal-Castellano, Isabelle
Carlson, Mark
Reznik, Gabriel
Siedlecki, James
Kane, John
Dostalova, Zuzana
Miao, Hua
Rubin-Bejerano, Ifat
author_facet Sansal-Castellano, Isabelle
Carlson, Mark
Reznik, Gabriel
Siedlecki, James
Kane, John
Dostalova, Zuzana
Miao, Hua
Rubin-Bejerano, Ifat
author_sort Sansal-Castellano, Isabelle
collection PubMed
description
format Online
Article
Text
id pubmed-4652514
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46525142015-11-25 The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody Sansal-Castellano, Isabelle Carlson, Mark Reznik, Gabriel Siedlecki, James Kane, John Dostalova, Zuzana Miao, Hua Rubin-Bejerano, Ifat J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652514/ http://dx.doi.org/10.1186/2051-1426-3-S2-P414 Text en Copyright © 2015 Sansal-Castellano et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Sansal-Castellano, Isabelle
Carlson, Mark
Reznik, Gabriel
Siedlecki, James
Kane, John
Dostalova, Zuzana
Miao, Hua
Rubin-Bejerano, Ifat
The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
title The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
title_full The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
title_fullStr The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
title_full_unstemmed The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
title_short The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
title_sort mabxcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-ctla4 antibody
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652514/
http://dx.doi.org/10.1186/2051-1426-3-S2-P414
work_keys_str_mv AT sansalcastellanoisabelle themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT carlsonmark themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT reznikgabriel themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT siedleckijames themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT kanejohn themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT dostalovazuzana themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT miaohua themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT rubinbejeranoifat themabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT sansalcastellanoisabelle mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT carlsonmark mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT reznikgabriel mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT siedleckijames mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT kanejohn mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT dostalovazuzana mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT miaohua mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody
AT rubinbejeranoifat mabxciteplatformmodifiesthetumormicroenvironmentwhenappliedtoanimmuneoncologyantictla4antibody